Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medpace Holdings Inc (NQ: MEDP )

337.75 +0.87 (+0.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 397,369
Open 336.71
Bid (Size) 320.00 (1)
Ask (Size) 357.99 (3)
Prev. Close 336.88
Today's Range 332.19 - 340.00
52wk Range 227.21 - 459.77
Shares Outstanding 30,998,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Looking Into Medpace Hldgs's Recent Short Interest
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Cardlytics, Medpace, Customers Bancorp, and Ibotta and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
+10.52%
+10.52%
1 Month
-3.47%
-3.47%
3 Month
-16.07%
-16.07%
6 Month
-13.22%
-13.22%
1 Year
+39.75%
+39.75%

More News

Read More
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Assessing Medpace Hldgs: Insights From 9 Financial Analysts
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Medpace Hldgs
Via Benzinga
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
Via Benzinga
Medpace Holdings, Inc. to Report Third Quarter 2024 Financial Results on October 21, 2024
From Medpace Holdings, Inc.
Via Business Wire
How to Analyze a Balance Sheet
Via The Motley Fool
Here's How Much You Would Have Made Owning Medpace Hldgs Stock In The Last 5 Years
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
Via Benzinga
Looking Into Medpace Hldgs's Recent Short Interest
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Dril-Quip, LPL Financial, Methode, and Medpace and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Thermo Fisher Scientific Stock Sees RS Rating Jump To 81
Via Investor's Business Daily
The Investing Mosaic
Via The Motley Fool
MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Medpace Holdings, Inc. (MEDP)
From Kirby McInerney LLP
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Avantor Stock Earns 84 RS Rating
Via Investor's Business Daily
MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.